Search results

Filter

Filetype

Your search for "*" yielded 571084 hits

Researchers block protein that plays a key role in Alzheimer’s disease

This article is over 5 years old, and the information may therefore be outdated. In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer’s disease. When the researchers shut off the gene th

https://www.multipark.lu.se/article/researchers-block-protein-plays-key-role-alzheimers-disease - 2026-10-13

Minerva award to Tomas Deierborg

This article is over 5 years old, and the information may therefore be outdated. The Future Faculty is proud to present the 2019 Minerva Award to Tomas Deierborg, associate professor at the Department of Experimental Medical Sciences.The Minerva award selection committee's motivation for the choice is: "The core values of the Minerva award are honesty, trust, fairness, respect, responsibility and

https://www.multipark.lu.se/article/minerva-award-tomas-deierborg - 2026-10-13

Drawing Closer: Alzheimer’s Blood Test for Primary Care

This article is over 5 years old, and the information may therefore be outdated. In today’s JAMA Neurology, researchers led by Oskar Hansson, Lund University, Sweden, report how a fully automated immunoassay for plasma Aβ performed when they put it through its paces. Roche Diagnostic’s Elecsys system predicted Aβ-positive individuals with about 80 percent accuracy. That number improved by 5 percen

https://www.multipark.lu.se/article/drawing-closer-alzheimers-blood-test-primary-care - 2026-10-13

New PET Staging Scheme for Amyloid?

This article is over 5 years old, and the information may therefore be outdated. Scientists are becoming more nuanced in how they use amyloid scans—not just to detect the presence of Alzheimer’s pathology, but also to pinpoint disease stage. At this year’s Alzheimer’s Association International Conference, held July 13–18 in Los Angeles, researchers led by Niklas Mattsson and Oskar Hansson at Lund

https://www.multipark.lu.se/article/new-pet-staging-scheme-amyloid - 2026-10-13

Parkinson Skåne visits BMC

This article is over 5 years old, and the information may therefore be outdated. On October 30, MultiPark arranged, in collaboration with the Parkinson Skåne patient organization and Studieförbundet Vuxenskolan, a half-day study visit for the public to the Biomedical Center. Professor Angela Cenci Nilsson led the event and guided the audience through the afternoon.       The chair of Parkinson Skå

https://www.multipark.lu.se/article/parkinson-skane-visits-bmc - 2026-10-13

Congratulations Oskar Hansson on the list of highly cited 2019

This article is over 5 years old, and the information may therefore be outdated. Oskar Hansson, professor of neurology at Lund University and cheif physician at Skåne University Hospital, is included in this year´s list of highly cited researchers that Web of Science compiles each year.Read the article (in Swedish) on the Faculty of Medicine website.

https://www.multipark.lu.se/article/congratulations-oskar-hansson-list-highly-cited-2019 - 2026-10-13

Skiers had lower incidence of depression and vascular dementia – but not Alzheimer’s

This article is over 5 years old, and the information may therefore be outdated. Half as many diagnosed with depression, a delayed manifestation of Parkinson’s, a reduced risk of developing vascular dementia - but not Alzheimer’s. These connections were discovered by researchers when they compared 200 000 people who had participated in a long-distance cross-country ski race between 1989 and 2010 w

https://www.multipark.lu.se/article/skiers-had-lower-incidence-depression-and-vascular-dementia-not-alzheimers - 2026-10-13

High-tech method for uniquely targeted gene therapy developed

This article is over 5 years old, and the information may therefore be outdated. Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe that the new technology can be likened to dramatically accelerating evolution from millions of ye

https://www.multipark.lu.se/article/high-tech-method-uniquely-targeted-gene-therapy-developed - 2026-10-13

Blood test enables early diagnosis of Alzheimer's disease

This article is over 5 years old, and the information may therefore be outdated. Diagnosing Alzheimer's disease is often difficult, as several other conditions can cause similar symptoms. Researchers at Lund University in Sweden have now discovered a blood marker that can accurately diagnose Alzheimer’s in the early stages of the disease.Read the full article here

https://www.multipark.lu.se/article/blood-test-enables-early-diagnosis-alzheimers-disease - 2026-10-13

New imaging method sheds light on Alzheimer's disease

This article is over 5 years old, and the information may therefore be outdated. To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease. Researchers at Lund University in Sweden have tested a new imaging method for this purpose. The research is published in the journal A

https://www.multipark.lu.se/article/new-imaging-method-sheds-light-alzheimers-disease - 2026-10-13

New method provides unique insight into the development of the human brain

This article is over 5 years old, and the information may therefore be outdated. Stem cell researchers at Lund University in Sweden have developed a new research model of the early embryonic brain. The aim of the model is to study the very earliest stages of brain to understand how different regions in the brain are formed during embryonic development. With this new insight, researchers hope to be

https://www.multipark.lu.se/article/new-method-provides-unique-insight-development-human-brain - 2026-10-13

How toxic protein spreads in Alzheimer’s disease

This article is over 5 years old, and the information may therefore be outdated. Toxic versions of the protein tau are believed to cause death of neurons of the brain in Alzheimer’s disease. A new study published in Nature Communications shows that the spread of toxic tau in the human brain in elderly individuals may occur via connected neurons. The researchers could see that beta-amyloid facilita

https://www.multipark.lu.se/article/how-toxic-protein-spreads-alzheimers-disease - 2026-10-13

Message from the coordinator

This article is over 5 years old, and the information may therefore be outdated. From the coordinator:As we approach Midsommar, we in MultiPark can reflect on the extraordinary last few months and hope that our environment can return back more to meetings, seminars and productive exchanges after the summer. Although neurodegenerative diseases were less in the news because of Covid-19, people with

https://www.multipark.lu.se/article/message-coordinator - 2026-10-13

New research paves way for developing therapies that could slow down Alzheimer´s

This article is over 5 years old, and the information may therefore be outdated. Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by Alzheimer’s disease pathology. The study has been published in Stem Cell Reports.Read the full article here.See also interview wit

https://www.multipark.lu.se/article/new-research-paves-way-developing-therapies-could-slow-down-alzheimers - 2026-10-13

New blood test shows great promise in the diagnosis of Alzheimer’s disease

This article is over 5 years old, and the information may therefore be outdated. A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the J

https://www.multipark.lu.se/article/new-blood-test-shows-great-promise-diagnosis-alzheimers-disease - 2026-10-13

Millions from Michael J. Fox Foundation to improve diagnosis of Parkinson's

This article is over 5 years old, and the information may therefore be outdated. Around 20,000 people have been diagnosed with Parkinson's disease in Sweden. Today, there is no imaging method of changes in the brain that are believed to cause the disease. Researchers at Skåne University Hospital and Lund University have received nearly SEK 7 million from the Michael J Fox Foundation to develop an

https://www.multipark.lu.se/article/millions-michael-j-fox-foundation-improve-diagnosis-parkinsons - 2026-10-13

Of Four Aβ Antibodies, Only Aducanumab Stems Tide of Toxic Oligomers

This article is over 5 years old, and the information may therefore be outdated. Aducanumab was compared, in a blinded study, to three clinical-stage antibodies using chemical kinetics. The publication describes the use of chemical kinetic analysis to assess the mechanisms of action of four clinical stage anti-Aβ antibodies: aducanumab (Biogen), gantenerumab (Roche), bapineuzumab (Elan) and solane

https://www.multipark.lu.se/article/four-ab-antibodies-only-aducanumab-stems-tide-toxic-oligomers - 2026-10-13

App predicts risk of developing Alzheimer’s

This article is over 5 years old, and the information may therefore be outdated. A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual’s risk of developing Alzheimer’s disease. Using a model that combines the levels of two specific proteins in the blood of those with mild memory impairment, the researchers are able to predict the risk of developing Alz

https://www.multipark.lu.se/article/app-predicts-risk-developing-alzheimers - 2026-10-13